Oncology Commercialization and Marketing Solutions

Few therapeutic areas exhibit more clinical and operational intensity than oncology: with accelerated approvals, rapidly evolving standards of care, and a widespread reliance on infused therapies, success depends on a brand’s ground-level readiness to ensure patients can conveniently access care.

We work closely with our clients to position therapies clearly, build access strategies that account for real-world provider behavior, and lead omnichannel campaigns that engage all stakeholders in the oncology treatment journey.

How can we support your oncology therapy?

At TJP, we help clients navigate the access realities that shape oncology treatment, from provider-administered infusions with nuanced site-of-care economics to early access programs that connect trial outcomes to real-world care delivery.

Powerful oncology drug launch strategy and execution

Launching an oncology therapy means stepping into one of the most dynamic categories in healthcare, a unique market that exhibits less pressure from payer negotiations and more input from a diverse web of stakeholders (including specialty oncologists, academic researchers, patient advocacy groups, and institutional treatment centers).

We develop and execute integrated patient access, marketing, and market access strategies to ensure every touchpoint reinforces a cohesive, data-driven value story.

Deep experience supporting commercialization strategies across breast cancer, lung cancer, hematologic malignancies, and rare oncology indications

Support for early access program (EAP) design, rollout, and communication to pave the way for uptake ahead of formal approval

Strategies that translate dense clinical data into market-ready narratives that resonate across oncologists, payers, and advocacy stakeholders

Hands-on commercialization support, from pre-launch through post-launch optimization

Expert insight and feedback from the TJP Market Access Council, a standing resource for strategy consultation and marketing material evaluation

Comprehensive strategies to streamline patient access and provider coordination

Access challenges in oncology are more complex than ever. Payers demand clear biomarker-driven justification, real-world evidence, and pricing strategies that reflect line-of-therapy positioning. In combination with regimens and novel modalities like cell and gene therapies, reimbursement considerations require proactive planning and cross-functional coordination.

We help brands navigate these pressures with a strategy grounded in careful analysis of how coverage decisions are made, how diagnostics and companion tests influence access, and how site-of-care economics (particularly for infused therapies) shape provider behavior and patient treatment pathways.

We operationalize this strategy by developing concrete tools for the field, like templated scripts for oncologists introducing early access programs and checklists for coordinating care between providers and infusion centers.

Full-service support for multi-channel oncology marketing

Oncology brands must engage an audience that is both broad and highly specialized, including stakeholders like academic opinion leaders, busy community oncologists, and patient advocacy groups. We develop marketing approaches that:

Build brand platforms grounded in clinical evidence and tailored to complex mechanisms and high-acuity audiences.

Equip field teams with messaging and materials that address specific points of resistance across oncology sub-specialties.

Deliver high-impact content and campaigns across digital, in-person, and peer-to-peer channels.

How can we boost market access for your oncology therapy?

From pre-launch planning to post-launch pull-through, we help teams navigate the complexity of oncology with clarity.

We blend strategic perspective with proven, hands-on execution to help your therapy reach the patients who need it most.

Let us know how we can help.